Cantabio Pharmaceuticals Inc. Stock Other OTC
Equities
CTBO
US13808X2036
Biotechnology & Medical Research
Financials (USD)
Sales 2017 | - | Sales 2018 | - | Capitalization | 2.36M |
---|---|---|---|---|---|
Net income 2017 | -1M | Net income 2018 | -2M | EV / Sales 2017 | - |
Net Debt 2017 | 337K | Net Debt 2018 | 1.1M | EV / Sales 2018 | - |
P/E ratio 2017 * |
-
| P/E ratio 2018 |
-
| Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 29.99% |
Managers | Title | Age | Since |
---|---|---|---|
Gergely Tóth
FOU | Founder | 51 | 12-02-05 |
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 15-05-21 |
Max Zhu
BRD | Director/Board Member | 42 | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 15-05-21 |
Gergely Tóth
FOU | Founder | 51 | 12-02-05 |
Max Zhu
BRD | Director/Board Member | 42 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.84B | |
+46.90% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |